Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008

Archives of Internal Medicine

Volumn 170, Issue 1, 2010, Pages 66-74

  Patel, Pragna ^a   Mackellar, Duncan ^a   Simmons, Pat ^b   Uniyal, Apurva ^c   Gallagher, Kathleen ^d   Bennett, Berry ^e   Sullivan, Timothy J ^f   Kowalski, Alexis ^d   Parker, Monica M ^f   LaLota, Marlene ^b   Kerndt, Peter ^c   Sullivan, Patrick S ^g  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b FLORIDA DEPARTMENT OF HEALTH   (United States)

^c Los Angeles County Department of Public Health   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e Retrovirology Section   (United States)

^f WADSWORTH CENTER   (United States)

^g EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; VIRUS DIAGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS SERODIAGNOSIS; FLORIDA; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOASSAY; LOS ANGELES; MIDDLE AGED; NEW YORK; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 74549118267     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.445     Document Type: Article

References (53)

1. Quinn TC. Acute primary HIV infection. JAMA. 1997;278(1):58-62.
2. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324(14):961-964.
3. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324(14):954-960.
4. Tindall B, Evans L, Cunningham P, et al. Identification of HIV-1 in semen following primary HIV-1 infection. AIDS. 1992;6(9):949-952.
5. Pilcher CD, Shugars DC, Fiscus SA, et al. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment, and public health. AIDS. 2001;15(7):837-845.
6. Quinn TC, Wawer MJ, Sewankambo N, et al; Rakai Project Study Group. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342(13):921-929.
7. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(3):249-258.
8. Jacquez JA, Koopman JS, Simon CP, Longini IM Jr. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr. 1994;7(11):1169-1184.
9. Pilcher CD, Tien HC, Eron JJ Jr, et al; Quest Study; Duke-UNC-Emory Acute HIV Consortium. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189(10):1785-1792.
10. Pilcher CD, Eron JJ Jr, Vemazza PL, et al. Sexual transmission during the incubation period of primary HIV infection. JAMA. 2001;286(14):1713- 1714.
11. Yerly S, Vora S, Rizzardi P, et al; Swiss HIV Cohort Study. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS. 2001;15(17):2287-2292.
12. Pao D, Fisher M, Hué S, et al. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS. 2005;19(1):85-90.
13. Hightow-Weidman LB, Golin CE, Green K, Shaw ENP, MacDonald PDM, Leone PA. Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North Carolina [published online January 6, 2009]. AIDS Behav. 2009. doi:10.1007/s10461-008-9519-5.
14. Leynaert B, Downs AM, de Vincenzi I; European Study Group on Heterosexual Transmission of HIV. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. Am J Epidemiol. 1998;148(1):88-96.
15. Royce RA, Sena S, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997;336(15):1072-1078.
16. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis. 2008;198(5):687-693.
17. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191(9):1403-1409.
18. Brenner BG, Roger M, Routy JP, et al; Quebec Primary HIV Infection Study Group. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007;195(7):951-959.
19. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med. 2008;5(3):e50. doi:10.1371/journal.pmed.0050050.
20. Pinkerton SD. How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission? AIDS. 2007;21(12):1625-1629.
21. Rapatski BL, Suppe F, Yorke JA. HIV epidemics driven by late disease stage transmission. J Acquir Immune Defic Syndr. 2005;38(3):241-253.
22. Kilmarx PH, Hamers FF, Peterman TA. Living with HIV: experiences and perspectives of HIV-infected sexually transmitted disease clinic patients after post-test counseling. Sex Transm Dis. 1998;25(1):28-37.
23. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89(9):1397-1405.
24. Colfax GN, Buchbinder SP, Cornelisse PGA, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS. 2002;16(11):1529-1535.
25. Marks G, Crepaz N, Senterfitt W, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446-453.
26. Constantine NT, Saville RD, Dax EM. Retroviral Testing and Quality Assurance: Essentials for Laboratory Diagnosis. Halifax, Nova Scotia: MedMira Laboratories; 2005:147-151.
27. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871-1879.
28. Busch MP, Lee LLJ, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion. 1995;35(2):91-97.
29. Stramer SL, Glynn SA, Kleinman SH, et al; National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351(8):760-768.
30. Pilcher CD, McPherson JT, Leone PA, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA. 2002;288(2):216-221.
31. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med. 2005;352(18):1873- 1883.
32. Stekler J, Swenson PD, Wood RW, Handsfield HH, Golden MR. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS. 2005;19(12):1323-1325.
33. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in highrisk patients in California. J Acquir Immune Defic Syndr. 2006;42(1):75-79.
34. Truong HM, Grant RM, McFarland W, et al. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS. 2006;20(17):2193-2197.
35. Priddy FH, Pilcher CD, Moore RH, et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr. 2007;44(2):196-202.
36. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory test and clinical symptoms for identification of primary HIV infection. AIDS. 2002;16(8):1119-1129.
37. Cunningham PH, McNally LP, Finlayson R, et al. Enhanced surveillance of acute HIV-1 infection in inner Sydney [abstract WEPDC04]. Poster presented at: Fourth IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia.
38. Louie B, Wong E, Klausner JD, et al. Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol. 2008;46(4):1494-1497.
39. Aptima HIV-1 RNA Qualitative Assay [package insert]. San Diego, CA: GenProbe Inc; August 2008.
40. Ethridge S, Sullivan T, Bennett B, et al. Validating 16 member pooled APTIMA® HIV-1 RNA testing [abstract 55]. Paper presented at: 2007 HIV Diagnostics Conference; December 5, 2007; Atlanta, Georgia.
41. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons; 1981.
42. Rosner B. Fundamentals of Biostatistics. 5th ed. Duxbury, MA: Duxbury Press; 2000.
43. Rothman KJ, Boice JD Jr. Epidemiologic Analysis With a Programmable Calculator. Bethesda, MD: National Institutes of Health; 1979:31-32. NIH publication 79-1649.
44. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral and revised recommendation of HIV screening of pregnant women. MMWR Recomm Rep. 2001;50(RR-19):1-54.
45. Association of Public Health Laboratories. Public health laboratory issues in brief: 2006 HIV diagnostics survey. http://www.aphl.org/aphlprograms/ infectious/Documents/HIV-issue-brief-2007.pdf. Accessed October 16, 2008.
46. Centers for Disease Control and Prevention (CDC). Recommendations for partner services program for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep. 2008;57(RR-9):1-83.
47. Marcus JL, Bernstein KT, Klausner JD. Updated outcomes of partner notification for human immunodeficiency virus, San Francisco, 2004-2008 [published online April 1, 2009]. AIDS. 2009;23(8):1024-1026. doi:10.1097/QAD.0b013e32832921a7.
48. Hogben M, McNally T, McPheeters M, Hutchinson AB. The effectiveness of HIV partner counseling and referral services in increasing identification of HIV-positive individuals: a systematic review. Am J Prev Med. 2007;33(2)(suppl):S89-S100.
49. Golden MR, Hogben M, Potterat JJ, Handsfield HH. HIV partner notification in the United States: a national survey of program coverage and outcomes. Sex Transm Dis. 2004;31(12):709-712.
50. Brewer DD. Case-finding effectiveness of partner notification and cluster investigation for sexually transmitted diseases/HIV. Sex Transm Dis. 2005;32(2):78-83.
51. Klausner JD, Wolf W, Fischer-Ponce L, Zolt I, Katz MH. Tracing a syphilis outbreak through cyberspace. JAMA. 2000;284(4):447-449.
52. Centers for Disease Control and Prevention. Using the Internet for partner notification of sexually transmitted diseases: Los Angeles County, California, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(6):129-131.
53. Hogben M, Kachur R. Internet partner notification: another arrow in the quiver. Sex Transm Dis. 2008;35(2):117-118.